Company · NSRX
Nasus Pharma Ltd.
Name as listed on its exchange; filed with the SEC as Nasus Pharma Ltd.
Nasdaq's symbol directory lists NSRX on NYSE American as “Nasus Pharma Ltd. Ordinary Shares”.
In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($20K); 1 filing by holders of 5% or more.
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- Dan Benjamin Teleman, Chief Executive Officer bought $20K
Every trade (1)
- BUYDan Benjamin Teleman, Chief Executive Officer bought $20K
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- BALYASNY ASSET MANAGEMENT L.P. 9.99%
Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.